Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring <i>STAG2</i> mutations

• Agatheeswaran Subramaniam,
• Carl Sandén,
• Larissa Moura-Castro,
• Kristijonas Žemaitis,
• Ludwig Schmiderer,
• Aurelie Baudet,
• Alexandra Bäckström,
• Elin Arvidsson,
• Simon Hultmark,
• Natsumi Miharada,
• Mattias Magnusson,
• Kajsa Paulsson,
• Thoas Fioretos,
• Jonas Larsson

Affiliations

Agatheeswaran Subramaniam

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Carl Sandén

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund

Larissa Moura-Castro

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund

Kristijonas Žemaitis

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Ludwig Schmiderer

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Aurelie Baudet

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Alexandra Bäckström

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Elin Arvidsson

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Simon Hultmark

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Natsumi Miharada

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Mattias Magnusson

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund

Kajsa Paulsson

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund

Thoas Fioretos

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund

Jonas Larsson

Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund